SMC
CL icon

Smith, Moore & Co’s Colgate-Palmolive CL Stock Holding History

Smith, Moore & Co’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$811K Sell
9,516
-1,002
-10% -$89.3K 0.06% 245
2025
Q4 		$831K Sell
10,518
-1,267
-11% -$99.3K 0.06% 233
2025
Q3 		$942K Sell
11,785
-200
-2% -$17.1K 0.07% 219
2025
Q2 		$1.09M Sell
11,985
-1,022
-8% -$93.3K 0.09% 192
2025
Q1 		$1.22M Buy
13,007
+485
+4% +$43.4K 0.11% 175
2024
Q4 		$1.14M Sell
12,522
-2,666
-18% -$254K 0.1% 175
2024
Q3 		$1.58M Buy
15,188
+2,121
+16% +$216K 0.15% 127
2024
Q2 		$1.27M Sell
13,067
-332
-2% -$30.6K 0.13% 142
2024
Q1 		$1.21M Buy
13,399
+84
+0.6% +$7.12K 0.13% 147
2023
Q4 		$1.06M Buy
13,315
+1,519
+13% +$114K 0.13% 154
2023
Q3 		$839K Buy
11,796
+142
+1% +$10.6K 0.11% 164
2023
Q2 		$898K Buy
11,654
+438
+4% +$33.9K 0.11% 163
2023
Q1 		$843K Buy
11,216
+246
+2% +$18.3K 0.11% 169
2022
Q4 		$864K Buy
10,970
+85
+0.8% +$6.37K 0.12% 164
2022
Q3 		$765K Sell
10,885
-692
-6% -$54.3K 0.12% 163
2022
Q2 		$928K Buy
11,577
+7
+0.1% +$547 0.14% 145
2022
Q1 		$877K Buy
11,570
+7
+0.1% +$554 0.12% 174
2021
Q4 		$987K Sell
11,563
-23
-0.2% -$1.8K 0.14% 150
2021
Q3 		$876K Buy
11,586
+36
+0.3% +$2.86K 0.13% 160
2021
Q2 		$940K Sell
11,550
-194
-2% -$15.9K 0.14% 153
2021
Q1 		$926K Buy
11,744
+456
+4% +$35.7K 0.15% 143
2020
Q4 		$965K Sell
11,288
-869
-7% -$71.9K 0.18% 106
2020
Q3 		$938K Buy
12,157
+2,906
+31% +$222K 0.19% 99
2020
Q2 		$678K Sell
9,251
-5,718
-38% -$406K 0.15% 130
2020
Q1 		$993K Sell
14,969
-2,940
-16% -$207K 0.26% 74
2019
Q4 		$1.23M Sell
17,909
-63
-0.4% -$4.29K 0.26% 73
2019
Q3 		$1.32M Buy
17,972
+7
+0% +$508 0.29% 65
2019
Q2 		$1.29M Buy
17,965
+6
+0% +$426 0.29% 66
2019
Q1 		$1.23M Sell
17,959
-258
-1% -$16.7K 0.29% 66
2018
Q4 		$1.08M Buy
18,217
+7
+0% +$438 0.29% 66
2018
Q3 		$1.22M Buy
18,210
+1,139
+7% +$75.9K 0.28% 70
2018
Q2 		$1.11M Sell
17,071
-243
-1% -$15.9K 0.28% 69
2018
Q1 		$1.24M Buy
17,314
+4,222
+32% +$304K 0.33% 60
2017
Q4 		$988K Buy
13,092
+505
+4% +$36.9K 0.27% 71
2017
Q3 		$917K Buy
12,587
+952
+8% +$68.6K 0.26% 72
2017
Q2 		$863K Buy
11,635
+1,262
+12% +$93.7K 0.29% 64
2017
Q1 		$759K Buy
10,373
+32
+0.3% +$2.24K 0.27% 67
2016
Q4 		$677K Buy
10,341
+40
+0.4% +$2.74K 0.26% 74
2016
Q3 		$764K Buy
10,301
+36
+0.4% +$2.66K 0.31% 64
2016
Q2 		$751K Buy
10,265
+1
+0% +$71 0.31% 69
2016
Q1 		$725K Sell
10,264
-73
-0.7% -$4.86K 0.31% 70
2015
Q4 		$689K Sell
10,337
-318
-3% -$21.2K 0.34% 60
2015
Q3 		$676K Sell
10,655
-48
-0.4% -$3.14K 0.38% 44
2015
Q2 		$700K Sell
10,703
-19
-0.2% -$1.29K 0.36% 49
2015
Q1 		$743K Sell
10,722
-273
-2% -$18.9K 0.39% 44
2014
Q4 		$761K Buy
10,995
+1
+0% +$68 0.41% 45
2014
Q3 		$717K Buy
10,994
+4,296
+64% +$283K 0.4% 46
2014
Q2 		$457K Sell
6,698
-4,600
-41% -$308K 0.28% 68
2014
Q1 		$733K Sell
11,298
-1,070
-9% -$67.4K 0.44% 45
2013
Q4 		$807K Buy
+12,368
New +$792K 0.51% 38

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Smith, Moore & Co's CL Position: Q1 2026 in Review

Smith, Moore & Co reduced its Colgate-Palmolive (CL) stake by 9.5% in Q1 2026, selling an estimated $89.3K and leaving 9,516 shares worth $811K. The position accounts for 0.06% of the portfolio, ranked #245.

Smith, Moore & Co first reported a position in CL in Q4 2013 and has held it in 50 quarters since. The position peaked at $1.58M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Smith, Moore & Co held 9,516 shares of Colgate-Palmolive worth $811K as of Q1 2026.
  • Smith, Moore & Co sold 1,002 Colgate-Palmolive shares in Q1 2026, an estimated $89.3K.
  • Colgate-Palmolive made up 0.06% of Smith, Moore & Co's portfolio in Q1 2026, its #245 holding.
  • Smith, Moore & Co first reported a position in Colgate-Palmolive in Q4 2013 and has held it in 50 quarters since.
  • Smith, Moore & Co's Colgate-Palmolive position peaked at $1.58M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Smith, Moore & Co's 13F filing for Q1 2026, filed 5 May 2026.